Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 26

1.

Interleukin-8 Expression is Associated with Prostate Cancer Aggressiveness and Androgen Receptor Loss in Primary and Metastatic Prostate Cancer.

Maynard JP, Ertunc O, Kulac I, Baena Del Valle JA, De Marzo AM, Sfanos KS.

Mol Cancer Res. 2019 Oct 11. pii: molcanres.0595.2019. doi: 10.1158/1541-7786.MCR-19-0595. [Epub ahead of print]

PMID:
31604846
2.

Lactoferrin CpG Island Hypermethylation and Decoupling of mRNA and Protein Expression in the Early Stages of Prostate Carcinogenesis.

Porter CM, Haffner MC, Kulac I, Maynard JP, Baena-Del Valle JA, Isaacs WB, Yegnasubramanian S, De Marzo AM, Sfanos KS.

Am J Pathol. 2019 Sep 6. pii: S0002-9440(19)30698-4. doi: 10.1016/j.ajpath.2019.07.016. [Epub ahead of print]

PMID:
31499027
3.

Pilomyxoid astrocytomas: a short review.

Kulac I, Tihan T.

Brain Tumor Pathol. 2019 Apr;36(2):52-55. doi: 10.1007/s10014-019-00343-0. Epub 2019 Apr 3. Review.

PMID:
30945015
4.

If this is true, what does it imply? How end-user antibody validation facilitates insights into biology and disease.

Sfanos KS, Yegnasubramanian S, Nelson WG, Lotan TL, Kulac I, Hicks JL, Zheng Q, Bieberich CJ, Haffner MC, De Marzo AM.

Asian J Urol. 2019 Jan;6(1):10-25. doi: 10.1016/j.ajur.2018.11.006. Epub 2018 Dec 12. Review.

5.

Distribution of childhood skin diseases according to age and gender, a single institution experience.

Özçelik S, Kulaç İ, Yazıcı M, Öcal E.

Turk Pediatri Ars. 2018 Jun 1;53(2):105-112. doi: 10.5152/TurkPediatriArs.2018.6431. eCollection 2018 Jun.

6.

Molecular Pathology of High-Grade Prostatic Intraepithelial Neoplasia: Challenges and Opportunities.

Trabzonlu L, Kulac I, Zheng Q, Hicks JL, Haffner MC, Nelson WG, Sfanos KS, Ertunc O, Lotan TL, Heaphy CM, Meeker AK, Yegnasubramanian S, De Marzo AM.

Cold Spring Harb Perspect Med. 2019 Apr 1;9(4). pii: a030403. doi: 10.1101/cshperspect.a030403. Review.

PMID:
30082453
7.

Reduced immunohistochemical PTEN staining is associated with higher progression rate and recurrence episodes in non-invasive low-grade papillary urothelial carcinoma of the bladder.

Kulac I, Arslankoz S, Netto GJ, Ertoy Baydar D.

Virchows Arch. 2018 Jun;472(6):969-974. doi: 10.1007/s00428-018-2302-8. Epub 2018 Jan 24.

PMID:
29368083
8.

Profiling the Urinary Microbiome in Men with Positive versus Negative Biopsies for Prostate Cancer.

Shrestha E, White JR, Yu SH, Kulac I, Ertunc O, De Marzo AM, Yegnasubramanian S, Mangold LA, Partin AW, Sfanos KS.

J Urol. 2018 Jan;199(1):161-171. doi: 10.1016/j.juro.2017.08.001. Epub 2017 Aug 7.

9.

A Prospective Study of Chronic Inflammation in Benign Prostate Tissue and Risk of Prostate Cancer: Linked PCPT and SELECT Cohorts.

Platz EA, Kulac I, Barber JR, Drake CG, Joshu CE, Nelson WG, Lucia MS, Klein EA, Lippman SM, Parnes HL, Thompson IM, Goodman PJ, Tangen CM, De Marzo AM.

Cancer Epidemiol Biomarkers Prev. 2017 Oct;26(10):1549-1557. doi: 10.1158/1055-9965.EPI-17-0503. Epub 2017 Jul 28.

10.

Mesenchymal stem cell infiltration during neoplastic transformation of the human prostate.

Brennen WN, Zhang B, Kulac I, Kisteman LN, Antony L, Wang H, Meeker AK, De Marzo AM, Garraway IP, Denmeade SR, Isaacs JT.

Oncotarget. 2017 Jul 18;8(29):46710-46727. doi: 10.18632/oncotarget.17362.

11.

The Influence of Inverted Growth Pattern on Recurrence for Patients with Non-Invasive Low Grade Papillary Urothelial Carcinoma of Bladder.

Arslankoz S, Kulaç İ, Ertoy Baydar D.

Balkan Med J. 2017 Sep 29;34(5):464-468. doi: 10.4274/balkanmedj.2017.0081. Epub 2017 Apr 13.

12.

Novel Assay to Detect RNA Polymerase I Activity In Vivo.

Guner G, Sirajuddin P, Zheng Q, Bai B, Brodie A, Liu H, Af Hällström T, Kulac I, Laiho M, De Marzo AM.

Mol Cancer Res. 2017 May;15(5):577-584. doi: 10.1158/1541-7786.MCR-16-0246. Epub 2017 Jan 23.

13.

#InSituPathologists: how the #USCAP2015 meeting went viral on Twitter and founded the social media movement for the United States and Canadian Academy of Pathology.

Cohen D, Allen TC, Balci S, Cagle PT, Teruya-Feldstein J, Fine SW, Gondim DD, Hunt JL, Jacob J, Jewett K, Jiang X', Kaplan KJ, Kulac I, Meunier R, Riddle ND, Rush PS, Stall J, Stuart LN, Terrano D, Uthman E, Wasco MJ, Williamson SR, Wu RI, Gardner JM.

Mod Pathol. 2017 Feb;30(2):160-168. doi: 10.1038/modpathol.2016.223. Epub 2017 Jan 13.

14.

Low Intratumoral Mast Cells Are Associated With a Higher Risk of Prostate Cancer Recurrence.

Hempel HA, Cuka NS, Kulac I, Barber JR, Cornish TC, Platz EA, De Marzo AM, Sfanos KS.

Prostate. 2017 Mar;77(4):412-424. doi: 10.1002/pros.23280. Epub 2016 Nov 21.

PMID:
27868214
15.

Peripheral Zone Inflammation Is Not Strongly Associated With Lower Urinary Tract Symptom Incidence and Progression in the Placebo Arm of the Prostate Cancer Prevention Trial .

Kulac I, Gumuskaya B, Drake CG, Gonzalez B, Arnold KB, Goodman PJ, Kristal AR, Lucia MS, Thompson IM, Isaacs WB, De Marzo AM, Platz EA.

Prostate. 2016 Nov;76(15):1399-408. doi: 10.1002/pros.23224. Epub 2016 Jun 21.

16.

TP53 Staining in Tissue Samples of Chronic Lymphocytic Lymphoma Cases: An Immunohistochemical Survey of 51 Cases.

Kulaç İ, Demir Ç, Büyükaşık Y, Kutluk T, Üner A.

Turk J Haematol. 2017 Mar 1;34(1):34-39. doi: 10.4274/tjh.2016.0115. Epub 2016 May 12.

17.

Combined MYC Activation and Pten Loss Are Sufficient to Create Genomic Instability and Lethal Metastatic Prostate Cancer.

Hubbard GK, Mutton LN, Khalili M, McMullin RP, Hicks JL, Bianchi-Frias D, Horn LA, Kulac I, Moubarek MS, Nelson PS, Yegnasubramanian S, De Marzo AM, Bieberich CJ.

Cancer Res. 2016 Jan 15;76(2):283-92. doi: 10.1158/0008-5472.CAN-14-3280. Epub 2015 Nov 10.

18.

Molecular evidence that invasive adenocarcinoma can mimic prostatic intraepithelial neoplasia (PIN) and intraductal carcinoma through retrograde glandular colonization.

Haffner MC, Weier C, Xu MM, Vaghasia A, Gürel B, Gümüşkaya B, Esopi DM, Fedor H, Tan HL, Kulac I, Hicks J, Isaacs WB, Lotan TL, Nelson WG, Yegnasubramanian S, De Marzo AM.

J Pathol. 2016 Jan;238(1):31-41. doi: 10.1002/path.4628. Epub 2015 Oct 14.

19.

Effects of intra-abdominal pressure on adrenal gland function and morphology in rats.

Akkapulu N, Tirnaksiz MB, Kulac I, Tezel GG, Hayran M, Dogrul AB, Cetinkaya E, Yorganci K.

Int J Clin Exp Pathol. 2015 Mar 1;8(3):3230-7. eCollection 2015.

20.

Should Gleason 6 be labeled as cancer?

Kulac I, Haffner MC, Yegnasubramanian S, Epstein JI, De Marzo AM.

Curr Opin Urol. 2015 May;25(3):238-45. doi: 10.1097/MOU.0000000000000165. Review.

21.

Microscopic lesions of fallopian tubes in endometrioid carcinoma of the endometrium: How effective are the macroscopic tubal sampling techniques?

Kulac I, Usubutun A.

J Gynecol Oncol. 2013 Apr;24(2):114-9. doi: 10.3802/jgo.2013.24.2.114. Epub 2013 Apr 5.

22.

Relapse of multiple myeloma presenting with melena.

Yılmaz B, Köklü S, Kulaç I.

Dig Endosc. 2013 Mar;25(2):208-9. doi: 10.1111/den.12009. Epub 2012 Dec 17. No abstract available.

PMID:
23368727
23.

Occurrence of dysplasia and human papilloma virus typing in penile condylomas.

Baydar DE, Kulac I, Ozagari A, Guler Tezel G.

Urology. 2013 Jan;81(1):211.e9-15. doi: 10.1016/j.urology.2012.09.009. Epub 2012 Nov 13.

PMID:
23153936
24.

Does androgen receptor have a prognostic role in patients with estrogen/progesterone-negative and c-erbB-2-positive breast cancer?

Arslan C, Isik M, Guler G, Kulac I, Solak M, Turker B, Ozisik Y, Altundag K.

Am Surg. 2012 Sep;78(9):992-9.

PMID:
22964210
25.

A case of prostatic adenocarcinoma with aberrant p63 expression: presentation with detailed immunohistochemical study and FISH analysis.

Baydar DE, Kulac I, Gurel B, De Marzo A.

Int J Surg Pathol. 2011 Feb;19(1):131-6. doi: 10.1177/1066896910379478. Epub 2010 Aug 18.

PMID:
20719821
26.

Brilliant cresyl blue staining for screening hemoglobin H disease: Reticulocyte smear.

Kulaç İ, Ünal Ş, Gümrük F.

Turk J Haematol. 2009 Mar 5;26(1):45. No abstract available.

PMID:
27265113

Supplemental Content

Support Center